<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">Hyperhomocysteinemia</z:e> is thought to have an important role in the pathogenesis of <z:e sem="disease" ids="C1262005" disease_type="Disease or Syndrome" abbrv="">ischemic cerebral infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>When associated with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, it might worsen the neurologic course </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of the study was to clarify the relation between plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (<z:chebi fb="0" ids="17230">Hcy</z:chebi>) concentrations and silent <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> (SBI) in patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Total plasma <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels were prospectively studied in 46 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and SBI (group I), mean age 56+/-5.4 years, as compared to 38 diabetic patients without SBI (group II) and with 31 controls (group III) </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> concentrations were determined using a high-performance liquid chromatography assay </plain></SENT>
<SENT sid="5" pm="."><plain>The results were compared using the Student's t test </plain></SENT>
<SENT sid="6" pm="."><plain>The mean level of <z:chebi fb="0" ids="17230">Hcy</z:chebi> was 22.6+/-2.4 micromol/l in group I, 19.7+/-1.6 micromol/l in group II and 11.4+/-1.4 micromol/l in group III; between group I and group II p &lt; or = 0.001 </plain></SENT>
<SENT sid="7" pm="."><plain>These data are consistent with increased <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels in type 2 diabetic patients, contributing to the <z:hpo ids='HP_0003674'>onset</z:hpo> of SBI in some patients </plain></SENT>
<SENT sid="8" pm="."><plain>The phenomenon should be considered in any future strategy for the therapy of hyperhomocyst(e)inemia (HHcy) </plain></SENT>
</text></document>